When compared with non-CAD patients, the leptin mRNA expression in the EAT increased markedly (P < 0.05), but CTRP9 mRNA expression in the EAT reduced dramatically (P < 0.05, Figure 1) in CAD patients. The gene discussed is C1QTNF9; the disease is coronary artery disorder.